DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Colombel JF, Sands BE, Rutgeerts P. et al.
The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Gut 2016;
66: 839-851
Access:
We do not assume any responsibility for the contents of the web pages of other providers.